Table 3.
Multivariate Analysis of DFS in the Overall Series and TNBC Patients.
| HR (95% CI) | p | |
|---|---|---|
| Overall Patients | ||
| Age (>51 vs ≤51) | 0.77 (0.38–1.54) | 0.460 |
| Tumor size >2.0 vs ≤2.0) | 1.74 (0.84–3.61) | 0.137 |
| Grade (3 vs 1–2) | 2.41 (0.93–6.23) | 0.069 |
| cNHERF1 (≥70% vs <70%) | 0.93 (0.46–1.86) | 0.831 |
| nNHERF1 (>0% vs 0%) | 1.09 (0.40–2.98) | 0.865 |
| TILs (≥50% vs <50%) | 0.32 (0.12–0.87) | 0.026 |
| TNBC Patients | ||
| Age (>51 vs ≤51) | 0.39 (0.13–1.14) | 0.086 |
| Tumor size >2.0 vs ≤2.0) | 2.04 (0.78–5.35) | 0.145 |
| Grade (3 vs 1–2) | 3.37 (0.41–27.51) | 0.257 |
| cNHERF1 (≥70% vs <70%) | 0.57 (0.22–1.43) | 0.229 |
| nNHERF1 (>0% vs 0%) | 1.76 (0.44–6.98) | 0.423 |
| TILs (≥50% vs <50%) | 0.22 (0.06–0.80) | 0.022 |
Bold indicates P < 0.05.